ADMA Biologics, Inc.ADMANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank93
3Y CAGR+0.4%
5Y CAGR+9.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+0.4%/yr
vs +39.6%/yr prior
5Y CAGR
+9.4%/yr
Recent deceleration
Acceleration
-39.2pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $87.63M | -15.0% |
| 2024 | $103.15M | +100.9% |
| 2023 | $51.35M | -40.6% |
| 2022 | $86.52M | +69.4% |
| 2021 | $51.09M | -8.6% |
| 2020 | $55.92M | +109.0% |
| 2019 | $26.75M | +17.6% |
| 2018 | $22.75M | -47.2% |
| 2017 | $43.11M | +334.8% |
| 2016 | $9.91M | - |